KFDA orders death warnings

Published: 2007-08-20 06:58:00

Updated: 2007-08-20 06:58:00

On August 14, the government instructed drug makers to attach a stricter warning about the risk of death in patients when labeling recombinant human erythropoietin (epoetin alfa), produced using a mammalian cell line (Chinese hamster ovary cells).

Manufacturers of 14 epoetin alfa preparations...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK